Alexandra Frommlet

Q: What is Alexandra Frommlet email address?

Email Alexandra Frommlet at alexandra.frommlet@gmail.com and frommlet.alexandra@gene.com. This email is the most updated Alexandra Frommlet email found in 2026.

Q: How to contact Alexandra Frommlet?

To contact Alexandra Frommlet send an email to alexandra.frommlet@gmail.com or frommlet.alexandra@gene.com. (updated on October 30, 2024)

Scientist 4 (Biophysics) at Genentech | San Francisco, California, United States

About Alexandra Frommlet

As a Principal Scientific Researcher in Biophysics at Genentech, Alexandra Frommlet plays a pivotal role in the early stages of drug discovery, where her expertise in biophysical techniques significantly contributes to the development of innovative therapeutics. With a strong foundation in NMR, Surface Plasmon Resonance (SPR), Differential Scanning Fluorimetry (DSF), and Microscale Thermophoresis (MST), Alexandra is adept at optimizing assay conditions and conducting fragment-based hit and lead discovery campaigns. Her work involves the meticulous validation and characterization of small-molecule hits and leads, ensuring that only the most promising candidates advance through the drug development pipeline.

Alexandra thrives in collaborative, cross-disciplinary environments, where she leverages her skills in drug discovery and CRO management to drive projects forward. Her ability to independently navigate complex scientific challenges while fostering teamwork has been instrumental in the success of various drug discovery programs. Notably, her contributions to hit triaging and lead characterization have streamlined the identification of viable drug candidates, enhancing the efficiency of the discovery process.

In her current role, Alexandra is not only focused on the technical aspects of biophysics but also on the strategic integration of these techniques into broader drug discovery initiatives. By bridging the gap between biophysics and medicinal chemistry, she plays a crucial role in the identification of novel degraders and other innovative therapeutic modalities. Her commitment to advancing science and improving patient outcomes underscores her passion for biophysics and its application in the pharmaceutical industry, making her an invaluable asset to the Genentech team.

Alexandra Frommlet Work